Alemtuzumab is effective in patients with advanced, pretreated B-cell chronic lymphocytic leukemia: A nationwide study of routine use in Austria Veröffentlicht vonadmin 27. Juli 2020 Fiegl, M, Falkner, A, Hopfinger, G, Brugger, S, Zabernigg, A, Haslbauer, F, Andel, J, Thaler, J, Fridrik, M, Bauer, F, Mian, M, Tatzreiter, G, Zoier, N, Demirtas, D, Postner, G, Auberger, J, Gastl, G, Greil, R